In addition, it has also been shown that there is an association between common low-penetrance alleles in the TGFB signaling cascade and altered cervical cancer risk in women, a result that will underpin our immunophenotyping C6, and “immunotherapy” representing cervical squamous cell carcinoma is prognostic (33, 34). The gene discussed is TGFB1; the disease is cervical squamous cell carcinoma.